FEB 17, 2020 8:51 AM PST

Another HIV vaccine attempt fizzles out

WRITTEN BY: Tara Fernandez

Years of work and over $100 million in study costs have been abandoned after an HIV-vaccine tested in South Africa failed to protect treated individuals against HIV infections.

Over 5000 uninfected adults had enrolled in the study, with half receiving a shot of the vaccine and the other half being injected with a placebo. Much to the dismay of the study’s researchers, a routine safety and efficacy check-in revealed extremely disappointing results: 129 people from the vaccinated group and 123 from the placebo-treated population were found to be HIV-positive. 

On receiving these shocking results, President of the South African Medical Research Council (MRC) and study chair, Glenda Gray said, “I was catatonic.”

The research, partly funded by the Bill & Melinda Gates Foundation, was part of ongoing efforts to try to curb South Africa’s HIV epidemic that has been spiraling out of control. Over 20 percent of the world’s HIV-infected populations reside in South Africa, where an effective vaccine would have been instrumental in limiting the spread of the virus. “The epidemic is out of control here and we have to take steps to have a biomedical intervention,” said Gray.

This setback comes after a similar study in Thailand, conducted in 2009, also showed discouraging levels of protection. With an efficacy rate of just over 30 percent, researchers and drug developers were divided on whether to pursue the commercialization of the vaccine. 

To date, a major knowledge gap exists in both our understanding of the molecular immune pathways activated during HIV infection which have hampered researchers’ race to develop vaccines. Some lab-tested strategies have used neutralizing antibodies to thwart HIV infections, but in human trials, these have been hit or miss.

Two more HIV vaccine trials are set to deliver results in the next few years. However, with the track record of vaccination failures, global health organizations are pinning their hopes on other preventative and therapeutic measures to address the global HIV crisis.


Source: Science.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 29, 2019
Microbiology
OCT 29, 2019
Antibody Discovered That May be the Key to a Universal Flu Vaccine
Instead of designing a new flu vaccine every year, researchers have made a breakthrough that may lead to a single vaccine that protects against all strains....
NOV 01, 2019
Immunology
NOV 01, 2019
Immunity to HPV Can Prevent Skin Cancer
Scientists discovered a surprise benefit of low-risk human papillomaviruses (HPV), a typical resident of human skin. New research shows that these harmless...
FEB 01, 2020
Cell & Molecular Biology
FEB 01, 2020
Immunity in the Gut Ramps Up Around Mealtimes
Scientists have found that our immune system benefits when we eat regular meals....
FEB 19, 2020
Immunology
FEB 19, 2020
Rainbow trout hold the key to unravelling immunological mysteries
What do the gut microbiome, antibodies, and rainbow trout have in common? A lot, says researcher J. Oriol Sunyer from the University of Pennsylvania’...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
New Antibiotics Found Using AI Technology
Using AI, researchers at MIT have found a powerful new antibiotic capable of killing some of the most dangerous drug-resistant bacteria known to man. ...
MAR 28, 2020
Drug Discovery & Development
MAR 28, 2020
Could the Blood of Coronavirus Survivors Save Lives?
As the search for a treatment for coronavirus continues, a perhaps obscure-sounding candidate has begun to make headlines: blood containing antibodies from...
Loading Comments...